Hutch News

Hutch News

Stories tagged 'solid tumor'

Immunotherapy for ovarian cancer shows promise in mouse model, but hurdles remain

‘Tumor microenvironment’ poses unique challenges for T-cell therapy in solid tumors

April 4, 2017 | By Rachel Tompa / Fred Hutch News Service

A major roadblock to adopting T-cell therapy to solid tumors is what’s known as the tumor microenvironment, the local milieu of non-cancerous cells and molecules in and around the tumor. Fred Hutch researcher Dr. Kristin Anderson and her colleagues in Dr. Phil Greenberg's lab are working to overcome those barriers.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Oct. 6, 2016

Good News: Hutch internship program widens educational clout; outpatient clinics open in Uganda; Dr. Stefan Radtke earns DGTI award.

View story >


Beyond Ben Stiller's advice on PSA screening

The actor said a ‘prostate cancer test saved my life’; experts weigh in on when (and if) men should be screened

Oct. 5, 2016 | By Diane Mapes / Fred Hutch News Service

Actor Ben Stiller wrote in a new essay that a "prostate cancer test saved my life." Two cancer experts weigh in on when (and if) men should get the controversial screening test.

View story >


‘A crack in the door’: Glimpses of hope for the future of brain cancer care

Fred Hutch researchers discuss brain tumor treatments in the works — and what’s coming next

March 24, 2016 | By Rachel Tompa / Fred Hutch News Service

From precision medicine to lighting up tumors to gene therapy to the promise of immunotherapy, Fred Hutch researchers discuss the future of brain cancer care and treatment.

View story >


Pulmonologist Houghton joins Center

McGarry Houghton seeks answers to lung cancer's molecular basis, epidemiology

April 16, 2012 | By Colleen Steelquist

Dr. A. McGarry Houghton joined the Fred Hutchinson Cancer Research Center faculty last month. He plans to study mouse models of lung cancer in his new Clinical Research Division lab.

View story >


GI oncologist Coveler joins Center

Andrew Coveler adds cancer immunotherapy, translational research expertise to Clinical Research Division

April 9, 2012 | By Colleen Steelquist

Dr. Andrew Coveler has joined the Fred Hutchinson Cancer Research Center's Clinical Research Division faculty. His research encompasses early phase clinical trials of new cancer drugs and immune-based treatments like vaccines and antibodies.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.